These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 31400254)

  • 41. Male androgenetic alopecia.
    Rathnayake D; Sinclair R
    Expert Opin Pharmacother; 2010 Jun; 11(8):1295-304. PubMed ID: 20426708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Androgenetic alopecia: a review.
    Lolli F; Pallotti F; Rossi A; Fortuna MC; Caro G; Lenzi A; Sansone A; Lombardo F
    Endocrine; 2017 Jul; 57(1):9-17. PubMed ID: 28349362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma - with or without concurrent bimatoprost and/or minoxidil.
    Cohen PR
    Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature.
    Mercuri SR; Paolino G; Di Nicola MR; Vollono L
    Medicina (Kaunas); 2021 Mar; 57(4):. PubMed ID: 33806169
    [No Abstract]   [Full Text] [Related]  

  • 45. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis.
    Zhou Y; Chen C; Qu Q; Zhang C; Wang J; Fan Z; Miao Y; Hu Z
    Dermatol Ther; 2020 Jul; 33(4):e13741. PubMed ID: 32478968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol.
    Stevens J; Khetarpal S
    Int J Womens Dermatol; 2019 Feb; 5(1):46-51. PubMed ID: 30809579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical Treatment for Androgenetic Alopecia.
    Panchaprateep R
    Facial Plast Surg; 2024 Apr; 40(2):252-266. PubMed ID: 37871637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Female Androgenetic Alopecia: An Update on Diagnosis and Management.
    Starace M; Orlando G; Alessandrini A; Piraccini BM
    Am J Clin Dermatol; 2020 Feb; 21(1):69-84. PubMed ID: 31677111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Favorable effects of microneedling on long-standing androgenetic alopecia in an elderly man: A case report.
    Fujita J
    J Cosmet Dermatol; 2021 Feb; 20(2):588-590. PubMed ID: 32500595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
    Melo DF; Saceda-Corralo D; Tosti A; Weffort F; Carla Jorge M; de Barros CC; de Melo Carvalho R; Starace M
    Dermatol Ther; 2022 Feb; 35(2):e15247. PubMed ID: 34877759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of platelet-rich plasma in androgenetic alopecia patients.
    Butt G; Hussain I; Ahmed FJ; Choudhery MS
    J Cosmet Dermatol; 2019 Aug; 18(4):996-1001. PubMed ID: 30393988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response to Microneedling Treatment in Men with Androgenetic Alopecia Who Failed to Respond to Conventional Therapy.
    Dhurat R; Mathapati S
    Indian J Dermatol; 2015; 60(3):260-3. PubMed ID: 26120151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hormonal interaction and hair growth].
    Hoffmann R
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):787-92. PubMed ID: 12223960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
    Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promising therapies for treating and/or preventing androgenic alopecia.
    McElwee KJ; Shapiro JS
    Skin Therapy Lett; 2012 Jun; 17(6):1-4. PubMed ID: 22735503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgenetic alopecia.
    Otberg N; Finner AM; Shapiro J
    Endocrinol Metab Clin North Am; 2007 Jun; 36(2):379-98. PubMed ID: 17543725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia.
    Haddad N; Arruda S; Sadick N
    J Drugs Dermatol; 2022 Nov; 21(11):1166-1169. PubMed ID: 36342732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-level laser therapy as a treatment for androgenetic alopecia.
    Afifi L; Maranda EL; Zarei M; Delcanto GM; Falto-Aizpurua L; Kluijfhout WP; Jimenez JJ
    Lasers Surg Med; 2017 Jan; 49(1):27-39. PubMed ID: 27114071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.